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Interoffice Memorandum
SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: January 21, 2003
SUBJECT: Research News (#1)
____________________________________________________________________________________
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Kim Adcock (P.I. – Pharmacy Practice) – The Effects of Inhaled Fluticasone on
Inflammatory Mediators in Neonates at Risk for Chronic Lung Disease  (American College of
Clinical Pharmacy – Aventis Allergy/Asthma Research) - $2,402.00.
2. Dr. Charles Burandt (P.I. – RIPS/NCNPR) and Mr. Greg Swain (Co-P.I. – RIPS/NCNPR) –
Cultivation of Medicinal Plants on Small Mississippi Farms (Alcorn State University) -
$100,000.00 – July 1, 2002-June 30, 2005.
3. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Agreement for Teaching, Patient Care and Clinical
Research: Dr. Deborah King (University of Mississippi Internal Medicine Associates) –
$12,000.00 – January 1, 2003-December 31, 2003.
4. Dr. John Cleary (P.I. – Pharmacy Practice) – AMFN-001 (Intermune, Inc.) – $3,000.00 –
November 2002-November 2003.
5. Dr. Mark Hamann (P.I. – Pharmacognosy) – Unrestricted Research on Marine Natural
Products (Sequoia Sciences) – $3,000.00 – December 1, 2002-November 30, 2003.
6. Dr. Mark Hamann (P.I. – Pharmacognosy) – Marine Natural, Semisynthetic and Synthetic
Products as Leads for Drug Discovery Oncology (PharmaMar) - $78,750.00 – October 1, 2002-
September 30, 2003.
7. Dr. Christopher McCurdy (P.I. – Medicinal Chemistry) – Molecular Modeling, Design,
Synthesis, and Biological Evaluation of Novel Nociceptin/Orphanin FQ Receptor Ligands
(American Association of Colleges of Pharmacy) - $10,000.00 – December 2002-December 2003.
8. Dr. Rita Moraes (P.I. – RIPS/NCNPR) –American Mayapple and Eastern Red Cedar as
Potential Domestic Sources of the Anti-Cancer Compound Podophyllotoxin (Mississippi State
University/U.S. Department of Agriculture) - $53,438.00.
 
9. Dr. John Schetz (P.I. – Pharmacology) – Synthetic and Natural Small Molecule Zebra Mussel
Anti-Foulants (U.S. Environmental Protection Agency/EPSCOR/University of Southern
Mississippi) - $54,866.00 – July 1, 2002-June 30, 2003.
10. Dr. John Schetz (P.I. – Pharmacology) – Drug Interaction Sites on Dopamine and Serotonin
Receptors (University of Mississippi Medical Center/National Institutes of Health/COBRE) -
$230,827.00 – June 1, 2002-June 1, 2003.
11. Dr. Larry Walker (P.I. – RIPS/NCNPR) – Natural Products Acting via New Anti-Fungal
Targets (Georgetown University/National Institutes of Health) - $303,715.00 – May 1, 2002-
April 30, 2003.
12. Dr. Kristine Willett (P.I. – Pharmacology) – Screening of Environmental Contaminants
Detected in Mississippi Sediments…, Modification No. 3 (Mississippi State University/U.S.
Geological Survey) - $13,232.00 – March 1, 2002-February 28, 2003.
13. Dr. Kristine Willett (P.I. – Pharmacology) – Characterization of Flavonoids’ Ability to
Decrease CYP1B1 Activity (American Association of Colleges of Pharmacy/New Investigators
Program) - $10,000 – December 1, 2002-November 30, 2003.
14. Dr. John Williamson (P.I. – Medicinal Chemistry) – Mississippi Functional Genomics
Network: Pharmacogenetics Facility Component/BRIN (University of Southern
Mississippi/National Institutes of Health) - $348,000.00 – September 1, 2002-October 31, 2003.
15. Dr. Jordan Zjawiony (P.I.- Pharmacognosy) – Contract for Student Participation on
“Neuroendocrinology of the Skin and Connective Tissue: Steroidogenesis” Project (University of
Tennessee/National Institutes of Health) - $4,800.00 – October 1, 2002-July 31, 2003.
16. Dr. Jordan Zjawiony (P.I.- Pharmacognosy) – High Performance Liquid Chromatograph for
Research on Utilization of Natural Products in Agriculture and Forestry (U.S. Department of
Agriculture) - $25,000.00 – July 1, 2002-December 31, 2002.
The following PUBLICATIONS have appeared:
1. J.P. Bentley, N.E. Wilkin and D.J. McCaffrey – “Il Problema Della Compliance Dal Punto Di
Vista Del Paziente”, Medical Economics Italia.
2. B.R. Brown – “Managing HIV Disease: 2002”, Drug Topics, September 2, 2002.
3. W.M. Davis – “What Pharmacists Should Know about West Nile Virus”, Insights (State Journal
of the California Pharmacists Association), pp. 10-18, October 2002.
4. J.S. Hallam and D.R. Feller – “Recreational Sports Injuries and Patient Self-Care” – Drug
Topics, July 1, 2002.
5. S.G. Lalchandani, L. Lei, W. Zheng, M.M. Suni, B.M. Moore, S.B. Liggett, D. D. Miller and
D.R. Feller – “Yohimbine Dimers Exhibiting Selectivity for the Human a 2c–Adrenoceptor
Subtype”, The Journal of Pharmacology and Experimental Therapeutics, 303, pp. 979-984,
2002.
6. D.S. King, M.R. Wofford and J.L. Stewart – “The RAS: A Primary Target for Cardiovascular
Disease Prevention”, Drug Topics, November 4, 2002.
7. X.C. Li, A.S. Joshi, B. Tan, H.N. ElSohly, L.A. Walker, J.K. Zjawiony and D. Ferreira –
“Absolute Configuration, Conformation, and Chiral Properties of Flavanone-(3fi 8”)-Flavone
Biflavonoids from Rheedia acuminata”, Tetrahedron, 58, pp. 8709-8717, 2002.
8. S. Noble, R. Ogletree and D. King  – “For the Distaff Side: Hormone Replacement Therapy”,
Drug Topics, November 4, 2002.
9. A.R. Spies  – “The Controlled Substances Act: Legal Implications for R.Ph.s”, Drug Topics,
pp. 49-58, October 21, 2002.
10. J.G. Topliss, A.M. Clark, E. Ernst, C.D. Hufford, G.A.R. Johnston, J.M. Rimoldi and B.J.
Weimann – “Natural and Synthetic Substances Related to Human Health (IUPAC Technical
Report)”, Pure and Applied Chemistry, 74, pp. 1957-1985, 2002.
11. J.S. Williamson and C.M. Wyandt – “Quelling Gastroesophageal Reflux Disease”, Drug
Topics, December 16, 2002.
12. J.S. Williamson and C.M. Wyandt – “The Burden of Depression”, Drug Topics, November 18,
2002.
13. D.Y. Xie, S.B. Sharma, N.L. Paiva, D. Ferreira and R.A. Dixon – “Role of Anthocyanidin
Reductase, Encoded by BANYULS in Plant Flavonoid Biosynthesis”, Science, 299, pp. 396-399,
January 17, 2003.
TECHNOLOGY TRANSFER transactions:
In the interest of protecting confidential information, the names and titles associated with School of
Pharmacy invention disclosures and patent applications will no longer be published until after a patent
has issued.
Invention Disclosures Filed in 2002: 10
US Patent Applications Pending: 16
Recent Patents Granted: N/A
Patents Recently Assigned to UM:  PATENT NUMBER: 6,087,385
PATENT TITLE: Flavonoid derivatives
INVENTORS: Pershadsingh; Harrihar A., Avery; Mitchell A.
 PATENT NUMBER: 6,204,288
PATENT TITLE: 1,2-Dithiolane Derivatives
INVENTORS: Pershadsingh; Harrihar A., Avery; Mitchell A.
 PATENT NUMBER: 6,353,011
PATENT TITLE: 1,2-Dithiolane Derivatives
INVENTORS: Pershadsingh; Harrihar A., Avery; Mitchell A.
 PATENT NUMBER: 6,369,098
PATENT TITLE: Dithiolane derivatives
INVENTORS: Pershadsingh; Harrihar A., Avery; Mitchell A.
The following SPECIAL ANNOUNCEMENTS are also listed:
·  Dr. Walter Chambliss was elected Fellow of the American Pharmaceutical Association and will be
recognized at the APhA Annual Meeting in March 2003.
·  Dr. Mahmoud ElSohly was presented the 2002 Distinguished Alumni Award by the University of
Pittsburgh.
·  Dr. Leigh Ann Ramsey , Assistant Professor of Pharmacy Practice, has recently been notified by
the Board of Pharmaceutical Specialties (BPS) that she passed the board certification exam in
Pharmacotherapy.  Effective January 1, 2003, she became the fourth full-time, regular faculty
member of the School of Pharmacy to become credentialed as a Specialist by the BPS.  Only 2,068
pharmacists in the country are credentialed in this specialty area.  Leigh Ann practices at the
Pharmaceutical Care Clinic at the Jackson Medical Mall.
·  Faculty and Students of the Pharmaceutics Department made presentations at the Annual Meeting of
the American Association of Pharmaceutical Scientists in Toronto, Canada - November 10-14, 2002.
This is the most important meeting for the Pharmaceutics discipline, with approximately 10,000 in
attendance.  The department was well represented in a variety of research areas covered by the
presentations as shown below:
a. K. Gutta, M. Munjal, S. Ross, M. ElSohly and M.A. Repka – “Influence of &[Delta]9-
Tetrahydrocannabinol on the Bioadhesive Properties of Cellulosic Films”
b. M. Munjal, S. Ross, M. ElSohly and M. A. Repka – “Effect of Processing Temperature on
the Stability of &[Delta]9-Tetrahydrocannabinol in KlucelPolymer Matrix Systems”
c. K. Gutta, P. Mididoddi, and M. A. Repka – “Release Studies of Lidocaine-Incorporated
Cellulosic Films Produced by Hot-Melt Extrusion Technology”
d. S. P. Stodghill, S. Prodduturi, and M. A. Repka – “Solid-State Characterization of Hot-
Melt Extruded Films Containing Clotrimazole”
e. S. Prodduturi and M.A. Repka – “Drug Content and Adhesive Uniformity of Hot-Melt
Extruded Hydroxypropyl Cellulose Films Containing Clotrimazole”
f. P. Mididoddi and M. A. Repka – “Bioadhesive Properties Of Hot-Melt Extruded Drug
Delivery Systems On The Human Nail”
g. S. P. Stodghill and N. Pavuluri – “Thermal Analytical Methods in the Physical
Characterization of Select Nutraceuticals”
h. C. Illapakurthy and C. M. Wyandt – “Competitive Inclusion Comlexation in a Weak
Acid/Drug/Cyclodextrin System at Different pHs”
i. C. Illapakurthy, Y. A. Sabnis, S. P. Stodghill, and C. M. Wyandt – “Prediction of
Comlexation Free Energies Between Various Drugs and Hydroxypropyl Beta Cyclodextrin
Using Molecular Modeling”
j. S. Cheboyina and C. M. Wyandt – “Freeze Pelletization Technique for the Preparation of
Oral Immediate and Controlled Release Matrix Pellets”
k. V. S. Rudraraju and C. M. Wyandt – “Rheological Characterization of Microcrystalline
Cellulose/Sodium Carboxymethylcellulose Hydrogels: Cause of Thixotropy”
l. V. S. Rudraraju and C. M. Wyandt – “Rheological Characterization of Thixotropic
Hydrogels: Shear Thinning Behavior”
m. K. Shah, B. A. Avery and C. M. Wyandt – “Evaluation of Selected Commercial Preparations
of St. John's Wort”
n. K. Dutta, B. A. Avery and C. M. Wyandt – “Preformulation Evaluation of a Novel
Antimalarial Drug”.
Please continue to send me important research and graduate information so that I might share it with
your faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL
OF PHARMACY WEB PAGE!  Thank you.
cc: Dean Barbara G. Wells
Ms. Dabney Weems
